Breast and prostate cancer were the two cancers members sought most help with in the first nine months of Benenden Health’s tie-in with Reframe Cancer.
Data taken from 1 July 2025 to 31 March 2026 revealed breast cancer (35%) and prostate cancer (20%) accounted for most member interactions for diagnosis and support, followed by lung cancer (8.5%) and myeloma (5%).
Analysis also showed that 11% of members who had used the service so far were aged 40 – 49, with 19% aged 50 – 59 and 30% aged 60 – 69. One in five (20%) were aged 70 – 79 and 18% 80 – 89.
The majority of members enrol at the treatment (45%) and diagnosis stage (35%), while 12% enrol post-treatment or living with cancer stage, 6% enrol at the pre-diagnosis stage and 1% enrol post GP referral.
In terms of accessing the service, female members had used the service the most, accounting for 66% of members that used the service, compared to 34% who were male.
Looking at some of the regional differences, 23% of members who used the service were from London, 14% were from Kent and 13% were from Belfast.
‘Cancer does not discriminate’
Mark Stephenson, CEO of Reframe Cancer (pictured) said: “When we started our partnership with Benenden Health, our joint aim was to make affordable, clinically regulated cancer care accessible to as many people as possible.
“The data shows we have done just that. Younger and older members are using the service, and we are helping with clinical guidance and navigation across an array of cancers from breast cancer through to myeloma.
“Cancer doesn’t discriminate and one in two adults in the UK will get cancer during their lifetime. There is an increasing need to help provide patients with an affordable cancer care and navigation solution.
“This is especially true in light of the recent delivery of the NHS National Cancer Plan, which has some bold targets and aspirations around diagnosis and improving treatment times.
“While we hope these are met, it will take several more years to reach them, so workable, cost effective solutions that can be accessed easily by people of any age, whether they have access to digital resources or not, must be available to ensure everyone can access the best cancer care possible.”
Dr Cheryl Lythgoe, nurse consultant at Benenden Health, added: “As clinicians, we see every day how overwhelming a cancer diagnosis can be, not only for the individual but for their families too.
“The early data shows that our members are actively seeking trusted, clinically regulated guidance at the moments they need it most, particularly around breast and prostate cancer.
“Having Reframe Cancer’s CQC‑regulated nurse specialists available means our 875,000 members can access clear, compassionate support throughout diagnosis and treatment, regardless of their age or confidence with digital services.
“This partnership ensures that no one has to navigate the complexity of cancer care alone, and as national cancer services work towards ambitious targets, the strong engagement we’re seeing highlights just how vital accessible, personalised cancer support is.”